Categories Analysis, Industrials

It might not be the right time to invest in Expedia (EXPE). Here’s why

The slowdown in the business continued in the latest quarter, but the stock made a strong recovery and returned to the pre-pandemic levels

The slump in the travel industry was widely expected after the virus outbreak was declared a pandemic early this year. Travel booking companies like Expedia, Inc. (NASDAQ: EXPE) are looking at an uncertain future amid the deepening economic uncertainty. Currently, the general outlook on the industry is mixed, with the new wave of infections offsetting recovery hopes raised by the progress in vaccine rollout.

Stock Recovers

While it seems the problems of the industry are far from over, Expedia bettered its performance in the stock market since losing steam in the early days of the crisis. However, the prospects of the business getting back on track would depend on how the pandemic situation evolves. It might not be a good idea to invest in Expedia now, for the stock is expected to experience weakness in the coming months. It is not the right time to sell either. But it makes sense to keep an eye on it until a clear picture emerges.

On the positive side, there has been an improvement in the company’s cost structure. As the year comes to a close, Expedia’s business is more stabilized than earlier — after being battered by the pandemic in the first half — thanks to the improvement in bookings aided by a modest rebound in summer travel.

Losing Streak

Continuing the losing streak that started at the beginning of the year, the company reported a loss of $0.22 per share for the third quarter, which marked a deterioration from the year-ago period when it generated earnings of $3.38-per share. All the key business segments witnessed weakness during the quarter, resulting in a 58% fall in total revenues to $1.5 billion. Gross bookings were down 68%. The numbers, however, topped the market’s expectations.

Expedia earnings Q3 2020 earningsExpedia earnings Q3 2020 earningsExpedia earnings Q3 2020 earningsExpedia earnings Q3 2020 earnings

The management is bullish about the recently-rebranded vacation rental platform Vrbo, which is designed to provide customers a better booking experience. The company also looks to benefit from its ongoing efforts to recalibrate the technology infrastructure to optimize the platform for multi-brand operation, once normalcy returns to the market.

Roadblocks

More recently, the resurgence of coronavirus infections in key markets and reports of a mutant version of the virus spreading in the U.K dampened the recovery hopes. International airline traffic, the primary revenue source for the accommodation industry, continues to be affected and recovery is expected to be slow due to the fresh restrictions. Moreover, Expedia is operating in a highly competitive segment.

We’re trying to be very prudent here while we rebuild everything on the theory that we will be at our end state by the time COVID is over or more precisely, travel trends come back to more normal levels. And we believe, as I said before, that once that plumbing is rebuilt and once we’re ready for multi-brand that we will be able to not only maintain but grow share at similar or better profitability as we have had before.

Peter Maxwell Kern, chief executive officer of Expedia


TripAdvisor Q3 2020 Earnings Call Transcript


Currently, Expedia’s stock is trading sharply above the levels seen during the March-selloff, after making steady gains since then. It has gained 56% in the last six months alone, all along outperforming the market. At $126.67, the shares traded slightly higher on Thursday.

Looking for more insights?

Read the full conference call transcript here. It’s free!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top